DK1343909T3 - Fremgangsmåder til stort anlagt produktion af Kingle 2-plus-Serin-protease-domæne (K2S) af plasminogen hos prokaryoter - Google Patents

Fremgangsmåder til stort anlagt produktion af Kingle 2-plus-Serin-protease-domæne (K2S) af plasminogen hos prokaryoter

Info

Publication number
DK1343909T3
DK1343909T3 DK01996619T DK01996619T DK1343909T3 DK 1343909 T3 DK1343909 T3 DK 1343909T3 DK 01996619 T DK01996619 T DK 01996619T DK 01996619 T DK01996619 T DK 01996619T DK 1343909 T3 DK1343909 T3 DK 1343909T3
Authority
DK
Denmark
Prior art keywords
kingle
prokaryotes
plasminogen
methods
scale production
Prior art date
Application number
DK01996619T
Other languages
English (en)
Inventor
Rolf-Guenther Werner
Chatchai Tayapiwatana
Friedrich Goetz
Jiradej Manosroi
Aranya Manosroi
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK1343909T3 publication Critical patent/DK1343909T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK01996619T 2000-11-14 2001-11-08 Fremgangsmåder til stort anlagt produktion af Kingle 2-plus-Serin-protease-domæne (K2S) af plasminogen hos prokaryoter DK1343909T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0027782.2A GB0027782D0 (en) 2000-11-14 2000-11-14 Methods fro large scale protein productio in prokaryotes
PCT/EP2001/012920 WO2002040696A2 (en) 2000-11-14 2001-11-08 Methods for large scale protein production in prokaryotes

Publications (1)

Publication Number Publication Date
DK1343909T3 true DK1343909T3 (da) 2009-12-21

Family

ID=9903155

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01996619T DK1343909T3 (da) 2000-11-14 2001-11-08 Fremgangsmåder til stort anlagt produktion af Kingle 2-plus-Serin-protease-domæne (K2S) af plasminogen hos prokaryoter

Country Status (18)

Country Link
EP (1) EP1343909B1 (da)
JP (1) JP2004513648A (da)
KR (1) KR100857402B1 (da)
CN (1) CN100457909C (da)
AR (1) AR031336A1 (da)
AT (1) ATE440145T1 (da)
AU (1) AU2002221824A1 (da)
CA (1) CA2428643A1 (da)
CY (1) CY1110546T1 (da)
DE (1) DE60139635D1 (da)
DK (1) DK1343909T3 (da)
ES (1) ES2332124T3 (da)
GB (1) GB0027782D0 (da)
HK (1) HK1077848A1 (da)
MX (1) MXPA03004162A (da)
PT (1) PT1343909E (da)
UY (1) UY27021A1 (da)
WO (1) WO2002040696A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087412B2 (en) 2000-11-14 2006-08-08 Boehringer Ingelheim International Gmbh Methods for large scale protein production in prokaryotes
GB0027779D0 (en) * 2000-11-14 2000-12-27 Boehringer Ingelheim Int Methods for large scale production of recombinant dna-derived tpa or k2s molecules
US6955910B2 (en) 2000-11-14 2005-10-18 Boehringer Ingelheim International Gmbh Method for large scale production of recombinant DNA-derived TPA or K2S molecules
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
EP2336153B1 (en) 2003-11-21 2016-03-30 Pfenex Inc. Improved expression systems with SEC-system secretion
JP2008507294A (ja) 2004-07-26 2008-03-13 ダウ グローバル テクノロジーズ インコーポレイティド 菌株遺伝子操作による改善されたタンパク質発現のための方法
KR101491867B1 (ko) 2007-01-31 2015-02-10 피페넥스 인크. 증가된 발현을 위한 박테리아 리더 서열
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
JP5444553B2 (ja) 2007-04-27 2014-03-19 フェネックス インコーポレイテッド 微生物宿主を迅速にスクリーニングして、異種タンパク質発現の収率および／または質が改善されている特定の株を同定する方法
CN102770555B (zh) * 2009-11-17 2015-01-28 詹森生物科技公司 改善的细菌膜蛋白分泌
CN102924602B (zh) * 2011-08-08 2015-06-17 深圳市艾派格生物技术有限公司 金离子吸附蛋白表面展示系统及富集并回收金离子的方法
CN106188311B (zh) * 2016-07-18 2020-08-04 山东大学齐鲁医院 一种重组肿瘤坏死因子相关细胞凋亡诱导配体蛋白的制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
JPH05219963A (ja) * 1990-07-18 1993-08-31 Applied Immune Sci Inc 温度誘導分泌発現ベクターおよびその原核細胞での使用
US6027888A (en) * 1996-04-05 2000-02-22 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
EP1048732A1 (de) * 1999-04-26 2000-11-02 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von natürlich gefalteten und sekretierten Proteinen

Also Published As

Publication number Publication date
EP1343909A2 (en) 2003-09-17
WO2002040696A2 (en) 2002-05-23
ES2332124T3 (es) 2010-01-27
CA2428643A1 (en) 2002-05-23
DE60139635D1 (de) 2009-10-01
JP2004513648A (ja) 2004-05-13
AR031336A1 (es) 2003-09-17
KR100857402B1 (ko) 2008-09-08
WO2002040696A3 (en) 2002-09-19
CN100457909C (zh) 2009-02-04
KR20030051821A (ko) 2003-06-25
CY1110546T1 (el) 2015-04-29
HK1077848A1 (en) 2006-02-24
GB0027782D0 (en) 2000-12-27
ATE440145T1 (de) 2009-09-15
UY27021A1 (es) 2002-07-31
PT1343909E (pt) 2009-09-11
AU2002221824A1 (en) 2002-05-27
CN1628176A (zh) 2005-06-15
MXPA03004162A (es) 2004-04-20
EP1343909B1 (en) 2009-08-19

Similar Documents

Publication Publication Date Title
DK1343909T3 (da) Fremgangsmåder til stort anlagt produktion af Kingle 2-plus-Serin-protease-domæne (K2S) af plasminogen hos prokaryoter
AU1339302A (en) Biaryl compounds as serine protease inhibitors
EP1590442A4 (en) MACROCYCLIC HEPATITIS C SERIN PROTEASE INHIBITORS
ATE547412T1 (de) Inhibitoren von serinproteasen, insbesondere hcv- ns3-ns4a-protease
CY2012007I1 (el) Πεπτιδομιμητικοι αναστολεις πρωτεασης
HK1098164A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
NO20024797D0 (no) Makrosykliske NS3-serinproteaseinhibitorer for hepatitt C- virus, som omfatter N-sykliske P2-rester
NO20031702D0 (no) Nye serinprotease-gener relatert til DPPIV
HK1095594A1 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
EP1590442A3 (en) Macrocyclic hepatitis c serine protease inhibitors
NO20030272L (no) Nye peptider som NS3-serinproteaseinhibitorer for hepatitt C- virus
NO20030271D0 (no) Nye peptider som NS3-serinproteaseinhibitorer for hepatitt C- virus
PL373399A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
ATE461209T1 (de) Hcv ns-3 serine protease inhibitoren
PL375486A1 (en) Potent inhibitor of hcv serine protease
IS5028A (is) Serínpróteasatálmar, einkum við lifrarbólgu C veiru NS3 próteasa
NO20004697L (no) Benzoksazinoner/benzotiazinoner som serin protease inhibitorer
NO20025030D0 (no) Makrosykliske NS3-serinproteaseinhibitorer for hepatitt C- virus, som omfatter alkyl- og arylalanin-P2-rester
DE69830410D1 (de) Meta-benzamidinderivate als serinprotease-inhibitoren
DE60135066D1 (de) Wiederherstellungsverfahren für eine Arbeitseinheit
DK1334182T4 (da) Fremgangsmåde til fremstilling af ikke-bovint chymosin og anvendelse heraf
NO20004696L (no) Kinoloner som serinproteaseinhibitorer
IS5590A (is) Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar
NO20025005D0 (no) Proteaseinhibitorer
EP1594845A4 (en) BENZENE ACETAMIDE COMPOUNDS USEFUL AS SERINE PROTEASE INHIBITORS